Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cristobal Morales Portillo
Superior Efficacy of Insulin Degludec/Liraglutide Versus Insulin Glargine U100 as Add-On to Sodium-Glucose Co-Transporter-2 Inhibitor Therapy: A Randomized Clinical Trial in Patients With Uncontrolled Type 2 Diabetes
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
An Indirect Treatment Comparison of the Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine/Lixisenatide (iGlarLixi) in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin
Journal of Medical Economics
Health Policy
Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Degludec in Patients With Type 2 Diabetes: A Randomized, Open-Label, Crossover Study Using Continuous Glucose Monitoring Profiles
Journal of Diabetes Investigation
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Cost-Effectiveness of Insulin Degludec Compared With Insulin Glargine for Patients With Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effect of Adding Insulin Degludec to Treatment in Patients With Type 2 Diabetes Inadequately Controlled With Metformin and Liraglutide: A Double-Blind Randomized Controlled Trial (BEGIN: ADD TO GLP-1 Study)
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Exenatide Add-On to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients With Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Efficacy and Safety of LY2963016 Insulin Glargine in Patients With Type 1 and Type 2 Diabetes Previously Treated With Insulin Glargine
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Achieve Control: A Pragmatic Clinical Trial of Insulin Glargine 300 U/mL Versus Other Basal Insulins in Insulin-Naïve Patients With Type 2 Diabetes
Postgraduate Medicine
Medicine
Comparison of Combined Tofogliflozin and Glargine, Tofogliflozin Added to Insulin, and Insulin Dose-Increase Therapy in Uncontrolled Type 2 Diabetes
Journal of Clinical Medicine Research
Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden
Applied Health Economics and Health Policy
Medicine
Health Policy
Economics
Econometrics
